AMUNNI, GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.120
NA - Nord America 1.807
AS - Asia 240
AF - Africa 5
Totale 4.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.799
PL - Polonia 1.058
IT - Italia 348
SE - Svezia 225
IE - Irlanda 157
HK - Hong Kong 98
UA - Ucraina 88
DE - Germania 69
RU - Federazione Russa 67
GB - Regno Unito 48
CN - Cina 47
SG - Singapore 37
FI - Finlandia 35
VN - Vietnam 18
JO - Giordania 16
TR - Turchia 16
FR - Francia 9
CA - Canada 8
CH - Svizzera 8
SC - Seychelles 5
IN - India 4
BE - Belgio 3
IL - Israele 2
NL - Olanda 2
AT - Austria 1
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
PT - Portogallo 1
Totale 4.172
Salva come PNG Salva come JPEG
Città #
Warsaw 1.058
Fairfield 258
Chandler 218
Dublin 157
Jacksonville 153
Woodbridge 150
Ashburn 143
Houston 102
Seattle 93
Wilmington 89
Cambridge 85
Hong Kong 66
Altamura 44
Lawrence 44
Ann Arbor 41
Princeton 41
Boardman 30
Medford 29
Buffalo 28
Singapore 26
Milan 25
Boston 22
Shanghai 21
Beijing 20
Dong Ket 16
San Diego 16
Florence 14
Izmir 13
Rome 12
Bari 9
Los Angeles 8
Norwalk 8
Salerno 8
Moscow 7
Toronto 7
Bern 6
Frankfurt Am Main 5
Hillsboro 5
London 5
Verona 5
New York 4
Phoenix 4
Pontedera 4
Portoferraio 4
Torregrotta 4
Viareggio 4
West Jordan 4
Andover 3
Aversa 3
Bozzolo 3
Düsseldorf 3
Erba 3
Kent 3
Monsummano Terme 3
Siena 3
Siracusa 3
Stagno 3
Arzano 2
Brussels 2
Calcinaia 2
Calenzano 2
Campobasso 2
Carpesica 2
Cascina 2
Castellana Grotte 2
Catania 2
Faenza 2
Falls Church 2
Genoa 2
Lucca 2
Lugano 2
Magliolo 2
Monzuno 2
Naples 2
Padova 2
Paris 2
Poggibonsi 2
Prato 2
Redmond 2
San Severo 2
Scandicci 2
Serravalle Scrivia 2
Tappahannock 2
Tel Aviv 2
Termini Imerese 2
Torino 2
Turin 2
Vicchio 2
Ambrogio 1
Antwerp 1
Atlanta 1
Auburn Hills 1
Bologna 1
Bremen 1
Brno 1
Capannori 1
Capodrise 1
Capua 1
Cernobbio 1
Cittadella 1
Totale 3.219
Salva come PNG Salva come JPEG
Nome #
Raccomandazioni cliniche per il carcinoma mammario 234
C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus. 233
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. 225
THE USE OF INTRAVENOUS METHOTREXATE IN THE TREATMENT OF ECTOPIC PREGNANCY 224
EXPRESSION OF INDUCILE NITRIC OXIDE SYNTHASE AND CYCLOOXYGENASE-2 IN OVARIAN CANCER: CORRRELATION WITH CLINICAL OUTCOME 223
C-KIT EXPRESSION AND CORRELATION WITH CHEMOTERAPY RESISTANCE IN OVARIAN CARCINOMA: AN IMMUNOCYTOCHEMICAL STUDY 216
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 213
Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. 184
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 179
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 105
Aspetti psicosociali dell’adattamento alla malattia in pazienti oncologiche 104
Microvessel density in ovarian carcinoma: computer image analysis in patients with shorter and longer survival. 103
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin 101
THE PROTOONCOGENE C-KIT IS EXPRESSED IN LEIOMYOSARCOMAS OF THE UTERUS 100
Early life events and gynaecological cancer: a pilot study 100
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 99
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 93
Uterine sarcoma: twenty-seven years of experience. 92
Cyclooxygenase-2, angiogenesis, tumor cell proliferation, P-glycoprotein in advanced ovarian serous carcinoma 89
Estrogen and progesterone receptors expression in uterine malignant smooth muscletumors: correlation with clinical outcome. 88
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. 88
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? 87
Cyclooxygenase-2 expression in uterine leiomyosarcomas. 80
Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly 79
Treatment of uterine sarcoma at the University of Florence from 1980-2001. 77
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients. 71
HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival. 70
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 65
Preoperative evaluation of tumor ploidy in endometrial carcinoma - An accurate tool to identify patients at risk for extrauterine disease and recurrence 58
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? 57
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. 51
Assessing psychological needs in female cancer patients: A tailored model 50
Uterine leiomyosarcomas express KIT protein but lack mutation(s) in exon 9 ofc-KIT. 47
Polychemotherapy in ovarian cancer: treatment with adriamycin, BCNU and cyclophosphamide vs. adrianycin and cyclophosphamide 46
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study 46
COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemiotherapy in ovarian cancer. 44
[Bcl-2 in ovarian carcinoma: a clinicopathologic, immunohistochemical and molecular study]. 44
HER-2\neu and Bcl-2 nel carcinoma ovarico: stusio clinico-patologico, immunoistochimico e molecolare in pazienti con breve e lunga sopravvivenza. 42
Use of electronic administrative databases to measure quality indicators of breast cancer care: Experience of five regional oncology networks in Italy 30
Indicators of the standard of care for melanoma: Tuscany data. 28
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards 22
Correlation of in vitro drug sensitivity and clinical response in ovarian carcinoma using an ATP-luminescence tumor chemosensitivity assay 20
Totale 4.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020807 0 94 28 77 97 96 80 115 73 50 85 12
2020/2021629 50 59 46 59 22 94 22 55 51 95 27 49
2021/2022294 13 35 15 9 11 8 18 19 9 16 69 72
2022/2023833 61 156 57 66 66 154 100 52 74 12 27 8
2023/2024334 12 32 55 24 21 29 11 87 6 19 26 12
2024/2025108 64 44 0 0 0 0 0 0 0 0 0 0
Totale 4.207